Selective Use of Antibiotics in Neonates Born to Mothers With Suspected Chorioamnionitis
NCT ID: NCT03576560
Last Updated: 2025-06-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
768 participants
OBSERVATIONAL
2017-06-26
2019-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Outcome of Neonates With GBS Positive Culture-12 Year Retrospective Study
NCT00326313
Early Antibiotic Therapy and Vaccinations in Preterm Infants
NCT05563753
Selective Antibiotics When Symptoms Develop Versus Universal Antibiotics for Preterm Neonates
NCT06377397
Group B Streptococcus Infection and PROM Incidince
NCT06735703
Pharmacokinetics and Safety of Ceftobiprole in Neonates and Infants up to 3 Months Treated With Systemic Antibiotics
NCT02527681
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Retrospective Chart Review
Retrospective Chart Review
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
35 Weeks
42 Weeks
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pediatrix
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
John Wimmer, MD
Role: PRINCIPAL_INVESTIGATOR
MEDNAX Employee
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Women's Hospital of Greensboro
Greensboro, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16NE-Z035-6145
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.